Neuroendocrine peptides have been shown to play paramount roles in the regulation of the functions of the anterior pituitary gland and its target organs and thereby modulate growth, metabolism, reproduction and responses to stressors. The chemical and biological characterization of each new neuroendocrine peptide has led to the revelation of additional actions, perhaps reflective of integrative roles, within the central nervous system and periphery. This program project focuses on the structure and function of peptides and their receptors involved in the regulation of corticotropic cells, including Corticotropin Releasing Factor (CRF), activin and Melanin Concentrating Hormone (MCH) and somatotropic cells, including Growth Hormone Releasing Factor (GRF), activin and somatostatin. We will also study select peptides or proteins derived from cDNA or genomic sequences such as the putative peptides NEI and NGE derived from the rat MCH precursor. We will explore the roles of transcription and tissue specific factors including the Cyclic AMP Response Element Binding protein (CREB) and POU-domain gene products which were characterized by Program participants and which may be important intracellular regulators of the development, proliferation and function of pituitary and neuroendocrine peptide producing cells. This multidisciplinary program involves six projects and five cores with three principal aims: 1) The identification by biochemical and/or recombinant DNA techniques of new regulatory peptides and their receptors; 2) The study of the regulation of neuroendocrine gene expression; 3) The investigation of the physiologic and pathophysiologic significance of selected neuroendocrine peptides especially CRF, GRF and new peptides such as mammalian MCH, activin and the CRF binding protein; 4) The design synthesis and pharmacologic evaluation of neuroendocrine peptide analogs of defined secondary structure in order to gain an understanding of the interactions between the peptides and their receptors. Some of these analogs might ultimately be applied to the investigation, diagnosis or management of conditions such as abnormal growth and development, endocrine neoplasia and stress related disorders of the endocrine, immune, hematopoietic and central nervous systems.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Program Projects (P01)
Project #
3P01DK026741-19S1
Application #
2825973
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Smith, Philip F
Project Start
1998-06-26
Project End
1999-05-31
Budget Start
1998-06-26
Budget End
1999-05-31
Support Year
19
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Spierling, Samantha R; Mattock, Maegan; Zorrilla, Eric P (2017) Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement. Physiol Behav 177:99-106
Erchegyi, Judit; Wang, Lixin; Gulyas, Jozsef et al. (2016) Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins). J Med Chem 59:854-66
Pilbrow, Anna P; Lewis, Kathy A; Perrin, Marilyn H et al. (2016) Cardiac CRFR1 Expression Is Elevated in Human Heart Failure and Modulated by Genetic Variation and Alternative Splicing. Endocrinology 157:4865-4874
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2016) Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease. Alzheimers Dement 12:527-37
Cui, Changhai; Noronha, Antonio; Warren, Kenneth R et al. (2015) Brain pathways to recovery from alcohol dependence. Alcohol 49:435-52
Perrin, Marilyn H; Tan, Laura A; Vaughan, Joan M et al. (2015) Characterization of a Pachymedusa dacnicolor-Sauvagine analog as a new high-affinity radioligand for corticotropin-releasing factor receptor studies. J Pharmacol Exp Ther 353:307-17
Zhang, Cheng; Kuo, Ching-Chang; Moghadam, Setareh H et al. (2015) Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model. J Alzheimers Dis 45:639-50
van der Meulen, Talitha; Huising, Mark O (2015) Role of transcription factors in the transdifferentiation of pancreatic islet cells. J Mol Endocrinol 54:R103-17
Radley, Jason J; Sawchenko, Paul E (2015) Evidence for involvement of a limbic paraventricular hypothalamic inhibitory network in hypothalamic-pituitary-adrenal axis adaptations to repeated stress. J Comp Neurol 523:2769-87
van der Meulen, Talitha; Donaldson, Cynthia J; Cáceres, Elena et al. (2015) Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion. Nat Med 21:769-76

Showing the most recent 10 out of 382 publications